Soulié E, Moulin V, Fourel V, Dubel L, Kantara-Doukoure M, Johanet C
Laboratoire central d'immunologie et d'hématologie, hôpital Saint-Antoine, Paris, France.
Ann Biol Clin (Paris). 1993;51(7-8):707-11.
About 94% of patients with typical features of primary biliary cirrhosis (PBC) have been shown to be anti-M2 positive. Today the relevance of anti-M2 antibodies as a diagnostic marker of PBC is well established. The usual method of detection is by indirect immunofluorescence with cryostat sections of rat organs. In our laboratory we have developed a second identification technique for these antibodies: Western-blotting. To compare immunofluorescence and immunoblotting results, we selected sera from 252 patients: 142 sera from patients with documented PBC, 50 from patients with another hepatic disease, 10 from patients with haematological lupus and 50 from healthy blood donors. We characterized antimitochondrial antibody M2 by the presence of one or more of five antigenic determinants: 65-70 kDa (a), 52-54 kDa (b), 44 kDa (c), 23-26 kDa (d) and 16-20 kDa (e). This technique is especially useful as a backup method intention for identifying a very slight or atypical fluorescence pattern.
约94%具有原发性胆汁性肝硬化(PBC)典型特征的患者被证明抗M2呈阳性。如今,抗M2抗体作为PBC诊断标志物的相关性已得到充分确立。通常的检测方法是采用大鼠器官冰冻切片进行间接免疫荧光检测。在我们实验室,我们开发了针对这些抗体的第二种鉴定技术:蛋白质免疫印迹法。为了比较免疫荧光和免疫印迹结果,我们从252名患者中选取了血清:142份来自确诊为PBC的患者,50份来自患有其他肝病的患者,10份来自患有血液系统狼疮的患者,50份来自健康献血者。我们通过五个抗原决定簇中一个或多个的存在来鉴定抗线粒体抗体M2:65 - 70 kDa(a)、52 - 54 kDa(b)、44 kDa(c)、23 - 26 kDa(d)和16 - 20 kDa(e)。这项技术作为一种备用方法,对于识别非常微弱或非典型的荧光模式特别有用。